Abhijeet J Lele Net Worth

The estimated Net Worth of Abhijeet J Lele is at least $57.3 ezer dollars as of 29 March 2019. Abhijeet Lele owns over 20,000 units of Agile Therapeutics Inc stock worth over $57,303 and over the last 11 years Abhijeet sold AGRX stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Abhijeet Lele AGRX stock SEC Form 4 insiders trading

Abhijeet has made over 1 trades of the Agile Therapeutics Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently Abhijeet bought 20,000 units of AGRX stock worth $30,800 on 29 March 2019.

The largest trade Abhijeet's ever made was buying 20,000 units of Agile Therapeutics Inc stock on 29 March 2019 worth over $30,800. On average, Abhijeet trades about 2,857 units every 0 days since 2014. As of 29 March 2019 Abhijeet still owns at least 37,949 units of Agile Therapeutics Inc stock.

You can see the complete history of Abhijeet Lele stock trades at the bottom of the page.

What's Abhijeet Lele's mailing address?

Abhijeet's mailing address filed with the SEC is 101, Poor Farm Road, Princeton, Mercer County, New Jersey, 08540, United States.

Insiders trading at Agile Therapeutics Inc

Over the last 11 years, insiders at Agile Therapeutics Inc have traded over $2,369,944 worth of Agile Therapeutics Inc stock and bought 24,967,253 units worth $79,522,957 . The most active insiders traders include Advisors Llcperceptive Life..., Ab Investor és Capital Iii Llc Care Capita.... On average, Agile Therapeutics Inc executives and independent directors trade stock every 69 days with the average trade being worth of $1,032,678. The most recent stock trade was executed by Alfred Altomari on 26 August 2022, trading 50,000 units of AGRX stock currently worth $22,500.

What does Agile Therapeutics Inc do?

agile therapeutics is a forward-thinking women's healthcare company dedicated to fulfilling the unmet health needs of today's women. our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. our lead product candidate, twirla®, (ethinyl estradiol and levonorgestrel transdermal system), also known as ag200-15, is a once-weekly prescription contraceptive patch that recently completed phase 3 trials. twirla is based on our proprietary transdermal patch technology, called skinfusion®, which is designed to provide advantages over currently available patches and is intended to optimize patch adhesion and patient wearability. for more information, please visit the company website at www.agiletherapeutics.com. connect with us on twitter at @agilether.

Complete history of Abhijeet Lele stock trades at Agile Therapeutics Inc

Agile Therapeutics Inc executives and stock owners

Agile Therapeutics Inc executives and other stock owners filed with the SEC include:

• Alfred Altomari,
  Chairman of the Board, Chief Executive Officer
• Alfred F. Altomari,
  Chairman & CEO
• Geoffrey Gilmore,
  Senior Vice President, General Counsel, Corporate Secretary
• Geoffrey P. Gilmore,
  Sr. VP, Gen. Counsel & Corp. Sec.
• Dr. Paul Korner M.B.A., M.D.,
  Sr. VP & Chief Medical Officer
• Robert Conway,
  Senior Vice President and Chief Supply Chain Officer
• Dennis P. Reilly,
  Sr. VP & CFO
• John Hubbard,
  Independent Director
• James Tursi,
  Independent Director
• Seth Fischer,
  Lead Independent Director
• Ajit Shetty,
  Independent Director
• Sharon Barbari,
  Independent Director
• Sandra Carson,
  Director
• Paul Korner,
  Chief Medical Officer
• Dennis Reilly,
  Chief Financial Officer, Senior Vice President
• Dr. Kathryn MacFarlane Pharm.D.,
  Advisor
• Robert G. Conway M.E.,
  Sr. VP & Chief Supply Chain Officer
• Joseph D'Urso,
  Controller
• Dr. Paul Korner,
  Sr. VP & Chief Medical Officer
• Dr. Elizabeth Ijeoma Onyemelukwe Garner M.D., M.P.H.,
  Consultant
• Robert G. Conway,
  Sr. VP & Chief Supply Chain Officer
• Amy Welsh,
  VP of Marketing
• Matthew Riley,
  Head of Investor Relations & Corp. Communications
• Jason Butch,
  VP & Chief Accounting Officer
• Katie Mac Farlane,
  Chief Commercial Officer
• Scott M Coiante,
  Chief Financial Officer
• Karen Hong,
  Director
• Renee Selman,
  Chief Commercial Officer
• Jay Schreiber Alain Pro Que...,
  
• William Mckee,
  Director
• Abhijeet J Lele,
  Director
• Amy Welsh,
  Chief Commercial Officer
• Capital Iii Llc Care Capita...,
  
• Elizabeth Garner,
  Sr. VP & Chief Medical Officer
• Advisors Llcperceptive Life...,
  
• Ab Investor,
  10% owner
• Andrew N Schiff,
  Director
• Josephine Torrente,
  Director